Patent · US Active

DACOS type NNRTIS amino acid ester derivative, preparation method thereof, pharmaceutical composition, and application thereof

US11420959B2 · kind B2 · utility

0Cited by

0References

19Claims

0Family size

Assignees

Inventors

Yanping He · Kunming, CN
Hongbin Zhang · College Station, US
Yongtang Zheng · Kunming, CN
Yufang Zhang · Weifang, CN
Chengrun Tang · Kunming, CN
Wei Ding · Hefei, CN
Liumeng Yang · Kunming, CN
Yiming Li · Lo Wu, CN

Key dates

Filing date	Mar 4, 2019
Grant date	Aug 23, 2022
Priority date	—
Expiry date	Jun 1, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D239/56
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is a DACOs-type NNRTIs amino acid ester derivative, a preparation method thereof, a pharmaceutical composition, and an application thereof. The structure of the DACOs-type NNRTIs amino acid ester derivative is represented by formula (I). The DACOs-type NNRTIs amino acid ester derivative represented by formula (I) can be used as HIV-1 inhibitors and for the preparation of a drug for treating and/or preventing immunodeficiency viruses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.